Erlotinib-mediated inhibition of EGFR signaling induces metabolic oxidative stress through NOX4.

Published

Journal Article

Redox regulation of epidermal growth factor receptor (EGFR) signaling helps protect cells against oxidative stress. In this study, we investigated whether the cytotoxicity of an EGFR tyrosine kinase inhibitor, erlotinib (ERL), was mediated by induction of oxidative stress in human head and neck cancer (HNSCC) cells. ERL elicited cytotoxicity in vitro and in vivo while increasing a panel of oxidative stress parameters which were all reversible by the antioxidant N-acetyl cysteine. Knockdown of EGFR by using siRNA similarly increased these oxidative stress parameters. Overexpression of mitochondrial targeted catalase but not superoxide dismutase reversed ERL-induced cytotoxicity. Consistent with a general role for NADPH oxidase (NOX) enzymes in ERL-induced oxidative stress, ERL-induced cytotoxicity was reversed by diphenylene iodonium, a NOX complex inhibitor. ERL reduced the expression of NOX1, NOX2, and NOX5 but induced the expression of NOX4. Knockdown of NOX4 by using siRNA protected HNSCC cells from ERL-induced cytotoxicity and oxidative stress. Our findings support the concept that ERL-induced cytotoxicity is based on a specific mechanism of oxidative stress mediated by hydrogen peroxide production through NOX4 signaling.

Full Text

Duke Authors

Cited Authors

  • Orcutt, KP; Parsons, AD; Sibenaller, ZA; Scarbrough, PM; Zhu, Y; Sobhakumari, A; Wilke, WW; Kalen, AL; Goswami, P; Miller, FJ; Spitz, DR; Simons, AL

Published Date

  • June 2011

Published In

Volume / Issue

  • 71 / 11

Start / End Page

  • 3932 - 3940

PubMed ID

  • 21482679

Pubmed Central ID

  • 21482679

Electronic International Standard Serial Number (EISSN)

  • 1538-7445

International Standard Serial Number (ISSN)

  • 0008-5472

Digital Object Identifier (DOI)

  • 10.1158/0008-5472.CAN-10-3425

Language

  • eng